Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
7.06
+0.31 (4.59%)
At close: Aug 19, 2026, 4:00 PM EDT
6.95
-0.11 (-1.56%)
After-hours: Aug 19, 2026, 4:33 PM EDT
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $419.26 million as of August 19, 2026. Its market cap has increased by 45.42% in one year.
Market Cap
419.26M
Enterprise Value
294.78M
1-Year Change
45.42%
Ranking
Category
Stock Price
$7.06
ChartMarket Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $419.26M, a decrease of -25.85%. That is a compound annual growth rate of -5.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 419.26M | 37.29% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 426.33M |
| ProKidney | 423.25M |
| EyePoint | 419.85M |
| Atea Pharmaceuticals | 418.67M |
| Compass Therapeutics | 416.00M |
| Fennec Pharmaceuticals | 414.84M |
| Lexeo Therapeutics | 408.57M |
| Scribe Therapeutics | 399.74M |